Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 379538, 12 pages
http://dx.doi.org/10.1155/2015/379538
Research Article

Apigenin Attenuates Atherogenesis through Inducing Macrophage Apoptosis via Inhibition of AKT Ser473 Phosphorylation and Downregulation of Plasminogen Activator Inhibitor-2

1Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
2Guangzhou Institute of Cardiovascular Disease, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China
3The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China
4Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
5Center for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong

Received 23 December 2014; Revised 24 March 2015; Accepted 24 March 2015

Academic Editor: Kota V. Ramana

Copyright © 2015 Ping Zeng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2013 update: a report from the American Heart Association,” Circulation, vol. 127, no. 1, p. e6-e245, 2013. View at Publisher · View at Google Scholar
  2. C. Weber and H. Noels, “Atherosclerosis: current pathogenesis and therapeutic options,” Nature Medicine, vol. 17, no. 11, pp. 1410–1422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Liu, D. P. Thewke, Y. R. Su, M. F. Linton, S. Fazio, and M. S. Sinensky, “Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 1, pp. 174–179, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. B. J. M. van Vlijmen, G. Gerritsen, A. L. Franken et al., “Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice,” Circulation Research, vol. 88, no. 8, pp. 780–786, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. V. R. Babaev, J. D. Chew, L. Ding et al., “Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis,” Cell Metabolism, vol. 8, no. 6, pp. 492–501, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hamada, M. Nakamura, M. T. N. Tran et al., “MafB promotes atherosclerosis by inhibiting foam-cell apoptosis,” Nature Communications, vol. 5, article 3147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Vargo, O. H. Voss, F. Poustka, A. J. Cardounel, E. Grotewold, and A. I. Doseff, “Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells,” Biochemical Pharmacology, vol. 72, no. 6, pp. 681–692, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Budhraja, N. Gao, Z. Zhang et al., “Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo,” Molecular Cancer Therapeutics, vol. 11, no. 1, pp. 132–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Shukla and S. Gupta, “Apigenin: a promising molecule for cancer prevention,” Pharmaceutical Research, vol. 27, no. 6, pp. 962–978, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Wright, J. P. E. Spencer, J. A. Lovegrove, and J. M. Gibbins, “Flavonoid inhibitory pharmacodynamics on platelet function in physiological environments,” Food and Function, vol. 4, no. 12, pp. 1803–1810, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Chunhua, L. Donglan, F. Xiuqiong et al., “Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT,” Journal of Nutritional Biochemistry, vol. 24, no. 10, pp. 1766–1775, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. H. G. Keizer, “The ‘Mevalonate hypothesis’: a cholesterol-independent alternative for the etiology of atherosclerosis,” Lipids in Health and Disease, vol. 11, article 149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. G. A. Naderi, S. Asgary, N. Sarraf-Zadegan, and H. Shirvany, “Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation,” Molecular and Cellular Biochemistry, vol. 246, no. 1-2, pp. 193–196, 2003. View at Google Scholar
  15. L. Yi, C. Y. Chen, X. Jin et al., “Differential suppression of intracellular reactive oxygen species-mediated signaling pathway in vascular endothelial cells by several subclasses of flavonoids,” Biochimie, vol. 94, no. 9, pp. 2035–2044, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Shukla, G. T. MacLennan, C. A. Flask et al., “Blockade of β-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice,” Cancer Research, vol. 67, no. 14, pp. 6925–6935, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Lin, Z. Yi, J. Diao et al., “ShaoYao decoction ameliorates colitis-associated colorectal cancer by downregulating proinflammatory cytokines and promoting epithelial-mesenchymal transition,” Journal of Translational Medicine, vol. 12, article 105, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Chunhua, L. Donglan, F. Xiuqiong et al., “Apigenin up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT,” Journal of Nutritional Biochemistry, vol. 24, no. 10, pp. 1766–1775, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Yang, Y. Su, D. Wang et al., “Tanshinol attenuates the deleterious effects of oxidative stress on osteoblastic differentiation via wnt/FoxO3a signaling,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 351895, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Y. Kwan, X. Fu, B. Liu et al., “Subcutaneous adipocytes promote melanoma cell growth by activating Akt signaling pathway: role of palmitic acid,” The Journal of Biological Chemistry, vol. 289, no. 44, pp. 30525–30537, 2014. View at Publisher · View at Google Scholar
  21. S. Tsimikas and Y. I. Miller, “Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease,” Current Pharmaceutical Design, vol. 17, no. 1, pp. 27–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. H. Chen, M. Riazy, E. M. Smith, C. G. Proud, U. P. Steinbrecher, and V. Duronio, “Oxidized LDL-mediated macrophage survival involves elongation factor-2 kinase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 1, pp. 92–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Jia, F. Zhou, P. Deng et al., “Interleukin 6 protects H2O2-induced cardiomyocytes injury through upregulation of prohibitin via STAT3 phosphorylation,” Cell Biochemistry and Function, vol. 30, no. 5, pp. 426–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. D. S. Goodsell, “Computational docking of biomolecular complexes with AutoDock,” Cold Spring Harbor Protocols, no. 5, 2009. View at Publisher · View at Google Scholar
  25. B. Liu, J. Huang, Y. Zhou et al., “Lentivirus-mediated LOX-1-RNA interference attenuates oxidative stress-induced apoptosis in myocardial cells,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 32, no. 2, pp. 165–168, 2012. View at Google Scholar
  26. H. J. Williams, E. A. Fisher, and D. R. Greaves, “Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention?” Journal of Innate Immunity, vol. 4, no. 5-6, pp. 498–508, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Buttari, E. Profumo, L. Segoni et al., “Resveratrol counteracts inflammation in human M1 and M2 macrophages upon challenge with 7-oxo-cholesterol: potential therapeutic implications in atherosclerosis,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 257543, 12 pages, 2014. View at Publisher · View at Google Scholar
  28. L. Yi, X. Jin, C.-Y. Chen et al., “Chemical structures of 4-oxo-flavonoids in relation to inhibition of oxidized low-density lipoprotein (LDL)-induced vascular endothelial dysfunction,” International Journal of Molecular Sciences, vol. 12, no. 9, pp. 5471–5489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Chandler, A. Woldu, A. Rahmadi et al., “Effects of plant-derived polyphenols on TNF-α and nitric oxide production induced by advanced glycation endproducts,” Molecular Nutrition and Food Research, vol. 54, supplement 2, pp. S141–S150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-R. Noh, I.-K. Lee, Y.-H. Kim et al., “Antiatherogenic effect of antioxidant polyphenols from Phellinus baumii in apolipoprotein E-deficient mice,” Annals of Nutrition & Metabolism, vol. 59, no. 2–4, pp. 145–153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Riazy, J. H. Chen, Y. Yamamato, H. Yamamato, V. Duronio, and U. P. Steinbrecher, “OxLDL-mediated survival of macrophages does not require LDL internalization or signalling by major pattern recognition receptors,” Biochemistry and Cell Biology, vol. 89, no. 4, pp. 387–395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Arai, J. M. Shelton, M. Chen et al., “A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development,” Cell Metabolism, vol. 1, no. 3, pp. 201–213, 2005. View at Google Scholar
  33. I. Tabas, “Macrophage death and defective inflammation resolution in atherosclerosis,” Nature Reviews Immunology, vol. 10, no. 1, pp. 36–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. R. S. Hundal, B. S. Salh, J. W. Schrader, A. Gómez-Muñoz, V. Duronio, and U. P. Steinbrecher, “Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway,” Journal of Lipid Research, vol. 42, no. 9, pp. 1483–1491, 2001. View at Google Scholar · View at Scopus
  35. J. Potempa, E. Korzus, and J. Travis, “The serpin superfamily of proteinase inhibitors: Structure, function, and regulation,” The Journal of Biological Chemistry, vol. 269, no. 23, pp. 15957–15960, 1994. View at Google Scholar · View at Scopus
  36. H. Ritchie, A. Jamieson, and N. A. Booth, “Peripheral blood monocyte synthesis of plasminogen activator inhibitor 2 in response to native and modified LDL,” Thrombosis and Haemostasis, vol. 74, no. 6, pp. 1521–1527, 1995. View at Google Scholar · View at Scopus
  37. J. A. Hamilton, G. A. Whitty, H. Stanton et al., “Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes,” Blood, vol. 82, no. 12, pp. 3616–3621, 1993. View at Google Scholar · View at Scopus
  38. N. J. Beauchamp, T. A. E. van Achterberg, M. A. Engelse, H. Pannekoek, and C. J. M. de Vries, “Gene expression profiling of resting and activated vascular smooth muscle cells by serial analysis of gene expression and clustering analysis,” Genomics, vol. 82, no. 3, pp. 288–299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. J. L. Dickinson, E. J. Bates, A. Ferrante, and T. M. Antalis, “Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis: evidence for an alternate biological function,” The Journal of Biological Chemistry, vol. 270, no. 46, pp. 27894–27904, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Delhase, S.-Y. Kim, H. Lee et al., “E177-E186 TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 4, pp. E177–E186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. J. L. Dickinson, E. J. Bates, A. Ferrante, and T. M. Antalis, “Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis: Evidence for an alternate biological function,” The Journal of Biological Chemistry, vol. 270, no. 46, pp. 27894–27904, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Kumar and C. Baglioni, “Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor Type-2,” The Journal of Biological Chemistry, vol. 266, no. 31, pp. 20960–20964, 1991. View at Google Scholar · View at Scopus
  43. H. Gan, G. W. Newman, and H. G. Remold, “Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4,” The Journal of Immunology, vol. 155, no. 3, pp. 1304–1315, 1995. View at Google Scholar · View at Scopus
  44. S. Cathelin, C. Rébé, L. Haddaoui et al., “Identification of proteins cleaved downstream of caspase activation in monocytes undergoing macrophage differentiation,” The Journal of Biological Chemistry, vol. 281, no. 26, pp. 17779–17788, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Lordan, C. O'Neill, and N. M. O'Brien, “Effects of apigenin, lycopene and astaxanthin on 7beta-hydroxycholesterol-induced apoptosis and Akt phosphorylation in U937 cells,” British Journal of Nutrition, vol. 100, no. 2, pp. 287–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. A. E. Rusiñol, D. Thewke, J. Liu, N. Freeman, S. R. Panini, and M. S. Sinensky, “AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis,” The Journal of Biological Chemistry, vol. 279, no. 2, pp. 1392–1399, 2004. View at Publisher · View at Google Scholar · View at Scopus